/
/
/

Cohance Lifesciences Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)446.30
Volume (₹)21.28 L
High (₹)471.55
Upper Circuit534.70
Low (₹)444.15
Lower Circuit356.50
Prev Close445.60
52W High (₹)917.85
Price464.10
52W Low (₹)266.70

Share Market Cap & Key Ratios Overview

M.Cap (₹)17065.80 Cr
Div. Yield (%)0.00
PE Ratio160.65
Debt to Equity0.04
Price to Book2.97
Book Value101.76
EPS (TTM)2.78
Face Value1.00
ROE (%)4.02

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
COHANCENSE
LTP
1W Low
1W High
Market cap (₹)
1769.2+9.2 (0.52%)
1725.50
1776.60
4,19,620Cr
9073.5-266.5 (-2.85%)
8937.50
9431.50
2,39,714Cr
4643.8-13.1 (-0.28%)
4551.80
4682
1,74,741Cr
1143.4+25.9 (2.32%)
1107.30
1150.90
1,12,119Cr
2027.1-9.5 (-0.47%)
2007.80
2069.20
1,10,008Cr
1332.1+31.1 (2.39%)
1300.20
1336.40
1,06,061Cr
1227.3+30.3 (2.53%)
1196.90
1250.70
1,01,339Cr
2359.6-8.9 (-0.38%)
2317.50
2426.80
96,244Cr
1679.7-13.3 (-0.79%)
1647.10
1715
95,590Cr
1981.8+25.3 (1.29%)
1925.70
1990.90
89,391Cr
464.1+23.1 (5.24%)
427.50
471.55
17,066Cr

Key Highlights of Cohance Lifesciences Ltd Balance Sheet

Cohance Lifesciences Ltd balance sheet discloses shareholders' funds of ₹38.26Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹38.26Cr, and the reserves and surplus of the company is ₹4423.77Cr.

The company has its non-current liabilities with total liabilities of ₹5113.2Cr as of 2026-03-31.

The current liabilities are ₹504.71Cr as of 2026-03-31. At the same time, current assets are ₹1668.67Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹925.26Cr and tangible assets of ₹2287.88Cr, provided in the Cohance Lifesciences Ltd financial statements.